In vitro evaluation of intestinal absorption of tiliroside from Edgeworthia gardneri (Wall.) Meisn.

References

• Alam, M.A., Al-Jenoobi, F.I. and Al-Mohizea, A.M., 2012. Everted gut sac model as a tool in pharmaceutical research: limitations and applications. Journal of pharmacy and pharmacology, 64, 326–336.
   PubMed Web of Science ®Google Scholar
• Arnold, Y.E., et al., 2019. Drug transport across porcine intestine using an Ussing chamber system: regional differences and the effect of P-glycoprotein and CYP3A4 activity on drug absorption. Pharmaceutics, 11.
   Web of Science ®Google Scholar
• Baiceanu, E., et al., 2015. Modulators of the human ABCC2: hope from natural sources? Future medicinal chemistry, 7, 2041–2063.
   PubMed Web of Science ®Google Scholar
• Ballent, M., et al., 2014. Intestinal drug transport: ex vivo evaluation of the interactions between ABC transporters and anthelmintic molecules. Journal of veterinary pharmacology and therapeutics, 37, 332–337.
   PubMed Web of Science ®Google Scholar
• Billat, P.A., et al., 2017. Models for drug absorption from the small intestine: where are we and where are we going? Drug discovery today, 22, 761–775.
   PubMed Web of Science ®Google Scholar
• Da Silva Junior, J.B., et al., 2015. Evaluating potential P-gp substrates: main aspects to choose the adequate permeability model for assessing gastrointestinal drug absorption. Mini reviews in medicinal chemistry, 15, 858–871.
   PubMed Web of Science ®Google Scholar
• Devi, S. and Kumar, V., 2020. Comprehensive structural analysis of cis- and trans-tiliroside and quercetrin from Malvastrum coromandelianum and their antioxidant activities. Arabian journal of chemistry, 13, 1720–1730.
   Web of Science ®Google Scholar
• Duan, J., et al., 2014. Transport characteristics of isorhamnetin across intestinal Caco-2 cell monolayers and the effects of transporters on it. Food and chemical toxicology, 66, 313–320.
   PubMed Web of Science ®Google Scholar
• Gao, D., et al., 2016. The flower of Edgeworthia gardneri (wall.) Meisn. suppresses adipogenesis through modulation of the AMPK pathway in 3T3-L1 adipocytes. Journal of ethnopharmacology, 191, 379–386.
   PubMed Web of Science ®Google Scholar
• Glaeser, H. and Fromm, M.F., 2008. Animal models and intestinal drug transport. Expert opinion on drug metabolism & toxicology, 4, 347–361.
   PubMed Web of Science ®Google Scholar
• Gleeson, J.P. and Mccartney, F., 2019. Striving towards the perfect in vitro oral drug absorption model. Trends in pharmacological sciences, 40, 720–724.
   PubMed Web of Science ®Google Scholar
• Goto, T., et al., 2012. Tiliroside, a glycosidic flavonoid, inhibits carbohydrate digestion and glucose absorption in the gastrointestinal tract. Molecular nutrition & food research, 56, 435–445.
   PubMed Web of Science ®Google Scholar
• Huang, J., et al., 2018. Interactions between emodin and efflux transporters on rat enterocyte by a validated Ussing chamber technique. Frontiers in pharmacology, 9, 646.
   PubMed Web of Science ®Google Scholar
• Ikechukwu, O.J. and Ifeanyi, O.S., 2016. The antidiabetic effects of the bioactive flavonoid (kaempferol-3-O-beta-D-6{P-coumaroyl}glucopyranoside) isolated From Allium cepa. Recent patents on anti-infective drug discovery, 11, 44–52.
   PubMedGoogle Scholar
• Jacqueroux, E., et al., 2020. In vitro assessment of P-gp and BCRP transporter-mediated drug-drug interactions of riociguat with direct oral anticoagulants. Fundamental & clinical pharmacology, 34, 109–119.
   PubMed Web of Science ®Google Scholar
• Jiang, C.P., et al., 2014. Intestinal absorptive transport of Genkwanin from Flos genkwa using a single-pass intestinal perfusion rat model. The American journal of Chinese medicine, 42, 349–359.
   PubMed Web of Science ®Google Scholar
• Kalapos-Kovacs, B., et al., 2015. Multiple ABC transporters efflux baicalin. Phytotherapy research, 29, 1987–1990.
   PubMed Web of Science ®Google Scholar
• Li, K., et al., 2019. Tiliroside is a new potential therapeutic drug for osteoporosis in mice. Journal of cellular physiology, 234, 16263–16274.
   PubMed Web of Science ®Google Scholar
• Li, Y., Revalde, J. and Paxton, J.W., 2017. The effects of dietary and herbal phytochemicals on drug transporters. Advanced drug delivery reviews, 116, 45–62.
   PubMed Web of Science ®Google Scholar
• Liu, X., et al., 2019. The in vivo pharmacokinetics, tissue distribution and excretion investigation of mesaconine in rats and its in vitro intestinal absorption study using UPLC-MS/MS. Xenobiotica, 49, 71–79.
   PubMed Web of Science ®Google Scholar
• Lu, X.Y., et al., 2010. Relative contribution of small and large intestine to deglycosylation and absorption of flavonoids from Chrysanthemun morifolium extract. Journal of agricultural and food chemistry, 58, 10661–10667.
   PubMed Web of Science ®Google Scholar
• Luo, Z., Morgan, M.R. and Day, A.J., 2015. Transport of trans-tiliroside (kaempferol-3-β-D-(6 ″-p-coumaroyl-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabolism in the small intestine. Xenobiotica, 45, 722–730.
   PubMed Web of Science ®Google Scholar
• Ma, Y.-Y., et al., 2015. α-Glucosidase inhibition and antihyperglycemic activity of phenolics from the flowers of Edgeworthia gardneri. Journal of agricultural and food chemistry, 63, 8162–8169.
   PubMed Web of Science ®Google Scholar
• Matsson, P., et al., 2009. Identification of Novel Specific and General Inhibitors of the Three Major Human ATP-Binding Cassette Transporters P-gp, BCRP and MRP2 Among Registered Drugs. Pharmaceutical research, 26, 1816–1831.
   PubMed Web of Science ®Google Scholar
• Mendes, C., et al., 2018. Intestinal permeability determinants of norfloxacin in Ussing chamber model. European journal of pharmaceutical sciences, 121, 236–242.
   PubMed Web of Science ®Google Scholar
• Miyake, M., et al., 2017. Prediction of drug intestinal absorption in human using the Ussing chamber system: a comparison of intestinal tissues from animals and humans. European journal of pharmaceutical sciences, 96, 373–380.
   PubMed Web of Science ®Google Scholar
• Miyake, M., et al., 2018. Evaluation of intestinal metabolism and absorption using the Ussing chamber system equipped with intestinal tissue from rats and dogs. European journal of pharmaceutics and biopharmaceutics, 122, 49–53.
   PubMed Web of Science ®Google Scholar
• Muller, J., et al., 2017. Expression, regulation and function of intestinal drug transporters: an update. Biological chemistry, 398, 175–192.
   PubMed Web of Science ®Google Scholar
• Murakami, T., 2017. Absorption sites of orally administered drugs in the small intestine. Expert opinion on drug discovery, 12, 1219–1232.
   PubMed Web of Science ®Google Scholar
• Nagy, I., et al., 2016. Membrane transporters in physiological barriers of pharmacological importance. Current pharmaceutical design, 22, 5347–5372.
   PubMed Web of Science ®Google Scholar
• Pan, L., et al., 2015. Neochamaejasmin B increases the bioavailability of chamaechromone coexisting in Stellera chamaejasme L. via inhibition of MRP2 and BCRP. International journal of pharmaceutics, 496, 440–447.
   PubMed Web of Science ®Google Scholar
• Roos, C., et al., 2017. Regional intestinal permeability in rats: a comparison of methods. Molecular pharmacology, 14, 4252–4261.
   Web of Science ®Google Scholar
• Rost, D., et al., 2002. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. American journal of physiology-gastrointestinal and liver physiology, 282, G720–G726.
   PubMed Web of Science ®Google Scholar
• Tocchetti, G.N., et al., 2016. Modulation of expression and activity of intestinal multidrug resistance-associated protein 2 by xenobiotics. Toxicology and applied pharmacology, 303, 45–57.
   PubMed Web of Science ®Google Scholar
• Velagapudi, R., El-Bakoush, A. and Olajide, O.A., 2018. Activation of Nrf2 pathway contributes to neuroprotection by the dietary flavonoid tiliroside. Molecular neurobiology, 55, 8103–8123.
   PubMed Web of Science ®Google Scholar
• Vertzoni, M., et al., 2019. Impact of regional differences along the gastrointestinal tract of healthy adults on oral drug absorption: an UNGAP review. European journal of pharmaceutical sciences, 134, 153–175.
   PubMed Web of Science ®Google Scholar
• Volpe, D.A., 2020. Advances in cell-based permeability assays to screen drugs for intestinal absorption. Expert opinion on drug discovery, 15, 539–549.
   PubMed Web of Science ®Google Scholar
• Williamson, G., et al., 2007. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2). Drug metabolism and disposition, 35, 1262–1268.
   PubMed Web of Science ®Google Scholar
• Xu, P., Xia, Z. and Lin, Y., 2012. Chemical constituents from Edgeworthia gardneri (Thymelaeaceae). Biochemical systematics and ecology, 45, 148–150.
   Web of Science ®Google Scholar
• Zan, T., et al., 2018. Simultaneous determination and pharmacokinetic study of three flavonoid glycosides in rat plasma by LC–MS/MS after oral administration of Rubus chingii Hu extract. Biomedical chromatography, 32, e4106.
   Web of Science ®Google Scholar
• Zhang, J., et al., 2012. Biopharmaceutics classification and intestinal absorption study of apigenin. International journal of pharmaceutics, 436, 311–317.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., et al., 2019. Edgeworthia gardneri (Wall.) Meisn. water extract improves diabetes and modulates gut microbiota. Journal of ethnopharmacology, 239, 111854.
   PubMed Web of Science ®Google Scholar
• Zhuang, M., et al., 2018. Islet protection and amelioration of type 2 diabetes mellitus by treatment with quercetin from the flowers of Edgeworthia gardneri. Drug design, development and therapy, Volume 12, 955–966.
   PubMed Web of Science ®Google Scholar